ReNeuron says stem cells improved motor function in stroke study

Another breakthrough awaits human kind as Stanford health physicians take on a new challenge and research trial on stem cell therapy. Stem cells that are derived from fat tissue will be tested and checked if it can work as an alternative to surgery.

This cell trial is approved by the Food and Drug Administration agency. It is the first to involve fat-derived stem cells. It works by using a liposuction to extract the fat tissue from the abdomen. The fat tissues will then be treated with a special enzyme and will be subjected to centrifuge to separate the stem cells.

The clinical trial will involve the body's natural healing process to heal shoulder injuries. Some people sometimes refer to shoulder concerns as a tooth ache which is likened to a dull pain that seems to stay. It is known that when a person reaches 45, the tendons go through a wear and tear process that causes small tears causing the pain as per KDLT News.

Adult stem cells will be used and not embryonic stem cells. Since adipose also known as fat stem cells are to be used, the same concept will be tested. The trial of the stem cell therapy will be done to those with torn rotator cuffs, Inforum reports.

Rotator cuff injury is a common condition experienced by Americans. This has sent over 6 million patients for surgical repairs by orthopedic surgeons yearly. The trial will be an opportunity to change the type of treatment done to those with rotated cuff injuries.

The result will be evaluated through a high-resolution MRI image along with an evaluation of the person's shoulder status in terms of strength, range of motion and perception of pain. Once the test turns out to be successful, stem cell therapy that is fat-derived will most likely be performed in a broad range of tissue repairs.

Source: https://goo.gl/Sv3MXX

Comments

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...

Stem Cells Therapy in India

Search This Blog